PLoS ONE (Jan 2021)

Central nervous system infection in the intensive care unit: Development and validation of a multi-parameter diagnostic prediction tool to identify suspected patients.

  • Hugo Boechat Andrade,
  • Ivan Rocha Ferreira da Silva,
  • Justin Lee Sim,
  • José Henrique Mello-Neto,
  • Pedro Henrique Nascimento Theodoro,
  • Mayara Secco Torres da Silva,
  • Margareth Catoia Varela,
  • Grazielle Viana Ramos,
  • Aline Ramos da Silva,
  • Fernando Augusto Bozza,
  • Jesus Soares,
  • Ermias D Belay,
  • James J Sejvar,
  • José Cerbino-Neto,
  • André Miguel Japiassú

DOI
https://doi.org/10.1371/journal.pone.0260551
Journal volume & issue
Vol. 16, no. 11
p. e0260551

Abstract

Read online

BackgroundCentral nervous system infections (CNSI) are diseases with high morbidity and mortality, and their diagnosis in the intensive care environment can be challenging. Objective: To develop and validate a diagnostic model to quickly screen intensive care patients with suspected CNSI using readily available clinical data.MethodsDerivation cohort: 783 patients admitted to an infectious diseases intensive care unit (ICU) in Oswaldo Cruz Foundation, Rio de Janeiro RJ, Brazil, for any reason, between 01/01/2012 and 06/30/2019, with a prevalence of 97 (12.4%) CNSI cases. Validation cohort 1: 163 patients prospectively collected, between 07/01/2019 and 07/01/2020, from the same ICU, with 15 (9.2%) CNSI cases. Validation cohort 2: 7,270 patients with 88 CNSI (1.21%) admitted to a neuro ICU in Chicago, IL, USA between 01/01/2014 and 06/30/2019. Prediction model: Multivariate logistic regression analysis was performed to construct the model, and Receiver Operating Characteristic (ROC) curve analysis was used for model validation. Eight predictors-age 2 cells/mm3, fever (≥38°C/100.4°F), focal neurologic deficit, Glasgow Coma Scale ResultsThe pool data's model had an Area Under the Receiver Operating Characteristics (AUC) curve of 0.892 (95% confidence interval 0.864-0.921, PConclusionsA promising and straightforward screening tool for central nervous system infections, with few and readily available clinical variables, was developed and had good accuracy, with internal and external validity.